Mohamed Fareh

Mohamed Fareh

Auto-generated profile, based on publicly available information

Mohamed Fareh

Peter MacCallum Cancer Centre

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Molecular Cell
Verified
Journal Article
Closed access
SHSimon J Hogg
Simon J Hogg
OMOlga Motorna
Olga Motorna
LCLeonie A Cluse
Leonie A Cluse
TJTimothy M Johanson
Timothy M Johanson
HCHannah D Coughlan
Hannah D Coughlan
RJRicky W Johnstone
Ricky W Johnstone

1 July 2011 in Cell Death & Differentiation
Verified
Journal Article
Closed access
MFM Fareh
M Fareh
LTL Turchi
L Turchi
VVV Virolle
V Virolle
DDD Debruyne
D Debruyne
FAF Almairac
F Almairac
Thierry VirolleThierry Virolle
Thierry Virolle

15 May 2015 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
BKBoseon Kim
Boseon Kim
MHMinju Ha
Minju Ha
LLLuuk Loeff
Luuk Loeff
HCHyeshik Chang
Hyeshik Chang
DSDhirendra K Simanshu
Dhirendra K Simanshu
VKV Narry Kim
V Narry Kim
Terminal uridylyl transferases (TUTs) function as integral regulators of microRNA (miRNA) biogenesis. Using biochemistry, single‐molecule, and deep sequencing techniques, we here investigate the mechanism by which human TUT7 (also known as ZCCHC6) recognizes and uridylates precursor miRNAs (pre‐miRNAs) in the absence of Lin28. We find that the overhang of a pre‐miRNA is the key structural element that is recognized by TUT7 and its paralogues, TUT4 (ZCCHC11) and TUT2 (GLD2/PAPD4). For group II pre‐miRNAs, which have a 1‐nt 3′ overhang, TUT7 restores the canonical end structure (2‐nt 3′ overhang) through mono‐uridylation, thereby promoting miRNA biogenesis. For pre‐miRNAs where the 3′ end is further recessed into the stem (as in 3′ trimmed pre‐miRNAs), TUT7 generates an oligo‐U tail that leads to degradation. In contrast to Lin28‐stimulated oligo‐uridylation, which is processive, a distributive mode is employed by TUT7 for both mono‐ and oligo‐uridylation in the absence of Lin28. The overhang length dictates the frequency (but not duration) of the TUT7‐RNA interaction, thus explaining how TUT7 differentiates pre‐miRNA species with different overhangs. Our study reveals dual roles and mechanisms of uridylation in repair and removal of defective pre‐miRNAs.

9 December 2016 in Nature Communications
Verified
Journal Article
Open access
MFMohamed Fareh
Mohamed Fareh
KYKyu-Hyeon Yeom
Kyu-Hyeon Yeom
AHAnna C. Haagsma
Anna C. Haagsma
Sweeny ChauhanSweeny Chauhan
Sweeny Chauhan
IHInha Heo
Inha Heo
CJChirlmin Joo
Chirlmin Joo
The RNA-binding protein TRBP is a central component of the Dicer complex. Despite a decade of biochemical and structural studies, the essential functionality of TRBP in microRNA (miRNA) biogenesis remains unknown. Here we show that TRBP is an integral cofactor for time-efficient Dicer processing in RNA-crowded environments. We competed for Dicer processing of pre-miRNA with a large amount of cellular RNA species and found that Dicer-TRBP, but not Dicer alone, remains resilient. To apprehend the mechanism of this substrate selectivity, we use single-molecule fluorescence. The real-time observation reveals that TRBP acts as a gatekeeper, precluding Dicer from engaging with pre-miRNA-like substrates. TRBP acquires the selectivity using the PAZ domain of Dicer, whereas Dicer moderates the RNA-binding affinity of TRBP for fast turnover. This coordinated action between TRBP and Dicer accomplishes an efficient way of discarding pre-miRNA-like substrates.

28 December 2016 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
Elias El-HabrElias El-Habr
Elias El-Habr
LDLuiz G. Dubois
Luiz G. Dubois
FBFanny Burel-Vandenbos
Fanny Burel-Vandenbos
ABAlexandra Bogeas
Alexandra Bogeas
JLJoanna Lipecka
Joanna Lipecka
MJMarie-pierre Junier
Marie-pierre Junier
Cell populations with differing proliferative, stem-like and tumorigenic states co-exist in most tumors and especially malignant gliomas. Whether metabolic variations can drive this heterogeneity by controlling dynamic changes in cell states is unknown. Metabolite profiling of human adult glioblastoma stem-like cells upon loss of their tumorigenicity revealed a switch in the catabolism of the GABA neurotransmitter toward enhanced production and secretion of its by-product GHB (4-hydroxybutyrate). This switch was driven by succinic semialdehyde dehydrogenase (SSADH) downregulation. Enhancing GHB levels via SSADH downregulation or GHB supplementation triggered cell conversion into a less aggressive phenotypic state. GHB affected adult glioblastoma cells with varying molecular profiles, along with cells from pediatric pontine gliomas. In all cell types, GHB acted by inhibiting α-ketoglutarate-dependent Ten–eleven Translocations (TET) activity, resulting in decreased levels of the 5-hydroxymethylcytosine epigenetic mark. In patients, low SSADH expression was correlated with high GHB/α-ketoglutarate ratios, and distinguished weakly proliferative/differentiated glioblastoma territories from proliferative/non-differentiated territories. Our findings support an active participation of metabolic variations in the genesis of tumor heterogeneity.

13 July 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MFMohamed Fareh
Mohamed Fareh
WZWei Zhao
Wei Zhao
WHWenxin Hu
Wenxin Hu
JCJoshua Misha Lewis Casan
Joshua Misha Lewis Casan
AKAmit Kumar
Amit Kumar
JTJoseph A. Trapani
Joseph A. Trapani
The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and Nucleocapsid transcripts achieved >98% silencing efficiency in virus-free models. Further, optimized and multiplexed Cas13b CRISPR RNAs (crRNAs) suppress viral replication in mammalian cells infected with replication-competent SARS-CoV-2, including the recently emerging dominant variant of concern B.1.1.7. The comprehensive mutagenesis of guide-target interaction demonstrated that single-nucleotide mismatches does not impair the capacity of a potent single crRNA to simultaneously suppress ancestral and mutated SARS-CoV-2 strains in infected mammalian cells, including the Spike D614G mutant. The specificity, efficiency and rapid deployment properties of reprogrammed Cas13b described here provide a molecular blueprint for antiviral drug development to suppress and prevent a wide range of SARS-CoV-2 mutants, and is readily adaptable to other emerging pathogenic viruses.